WTC
HZNP

WhitTier Trust Company’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

WhitTier Trust Company’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-224
Closed -$25.9K – 1235
2023
Q3 		$25.9K Hold
224
– – ﹤0.01% 767
2023
Q2 		$23K Hold
224
– – ﹤0.01% 830
2023
Q1 		$24.4K Sell
224
-19
-8% -$2.1K ﹤0.01% 809
2022
Q4 		$27.7K Buy
+243
New +$20.2K ﹤0.01% 784
2022
Q2 		– Sell
-600
Closed -$63K – 1212
2022
Q1 		$63K Buy
+600
New +$58.5K ﹤0.01% 635

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

WhitTier Trust Company's HZNP Position: Q4 2023 in Review

WhitTier Trust Company sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 224 shares — an estimated $25.9K sold.

WhitTier Trust Company first reported a position in HZNP in Q1 2022 and held it in 5 quarters. The position peaked at $63K in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • WhitTier Trust Company reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • WhitTier Trust Company sold 224 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $25.9K.
  • WhitTier Trust Company first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2022 and held it in 5 quarters.
  • WhitTier Trust Company's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $63K in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on WhitTier Trust Company's 13F filing for Q4 2023, filed 11 Jan 2024.